Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. Our community guidelines can be found here:

Connect with Pfizer Medical Affairs at the 2025 Crohn’s & Colitis Congress, Feb 6-8 in San Francisco and engage with experts in the field of #IBD.#ulcerativecolitis #CCCongress25

Click below to watch the first in a series of videos of an expert clinical dermatologist speaking about the burden of #InflammatorySkinDiseases and how to talk to your patients. #Dermatology

February is American Heart Month, a time to prioritize our cardiovascular health. Let's come together to raise awareness and make a difference! #AmericanHeartMonth #HeartHealth Visit our Pfizer Medical Portal for more resources in the link below:

Join us to explore our latest advancements in #Hemophilia research at European Association for Haemophilia and Allied Disorders- #EAHAD2025 congress from 4th to 7th Feb 2025, Milan, Italy. For more details, visit:

Missed our #HCOP2025 posters? You can find them on the Pfizer medical website. #healthcare #neurotwitter

Missed Pfizer Medical Affairs at #ACG2024? Visit the Pfizer Medical Portal to view our posters and abstracts on gastroenterology research. Click on the link to stay updated:

Discover data from a post-hoc analysis of an S1P receptor modulator in UC with & without concomitant treatments #ulcerativecolitis

Join Pfizer at Headache Cooperative of the Pacific 2025 Winter Conference to learn more about our latest #migraine data. #neurology #healthcare #neurotwitter

Attention Healthcare Providers: Pfizer’s latest publication from a real world vaccine effectiveness study on prevention of RSV in older adults is now available in JAMA Network Open. We invite you to read our findings by clicking the link: #RSV #vaccine

Join Pfizer Medical Affairs at Maui Derm in Hawaii from Jan 20-24, 2025, where we present our latest #Dermatology data focusing on therapies for #AtopicDermatitis and #AlopeciaAreata. Click to learn more:

View our new publication on #vitiligo treatment in a phase 2b extension study, focusing on efficacy and tolerability with and without narrow-band UVB therapy. #Dermatology Learn more:

A new publication in Cardiology and Therapy reveals the disparities associated with OAC primary nonadherence in newly diagnosed patients with AF. #atrialfibrillation #AFib Click to learn more.

A new publication providing data on pneumococcal serotype distribution among US adults hospitalized with pneumonia is now available in the journal, Open Forum Infectious Diseases. Click on the link below to learn more:

Check out the latest interactive resource from Pfizer Medical based on real-world evidence published in the last 10 years on use of certain oral anticoagulants in patients with atrial fibrillation or venous thromboembolism. #nvaf #vte Click here:

Thank you for joining us at #ASH24! If you were unable to attend, view our latest #hemophilia and #sicklecelldisease research presented at the congress.

We are pleased to announce a new publication on #pneumococcoal conjugate vaccine, highlighting its effectiveness against pneumococcal invasive disease in adults aged 65 years and older. Click on the link to know more:

We are pleased to announce a new publication on #RSV highlighting hospitalization burden post RSV outpatient diagnosis across six seasons. Click the link to learn more:

Visit this educational platform to understand the science of gene therapy, with a focus on principles specific to hemophilia.

Read about the latest findings of a JAKi for the treatment of ankylosing spondylitis. The post-hoc analysis highlights the safety and efficacy outcomes based on baseline BMI.

Don’t miss our oral presentation at #ASH24 on phase 3 results of a gene therapy for #hemophilia A: